Cyclin D1 plays a key regulatory role during the G 1 phase of the cell cycle and its gene is ampli®ed and overexpressed in many cancers. To address the relationship between cyclin D1 and other cell cycle regulatory proteins, we established human glioma and rodent ®broblast cell lines in which cyclin D1 expression could be regulated ectopically with tetracycline. In both of these cell lines, we found that ectopic expression of cyclin D1 in asynchronously growing cells was accompanied by increased levels of the p53 tumor suppressor protein and the cyclin/cdk inhibitor p21. Despite the induction of these cell cycle inhibitory proteins, cyclin D1-associated cdk kinase remained activated and the cells grew essentially like that of the parent cells. Although growth parameters were unchanged in these cells, morphological changes were clearly identi®able and anchorage independent growth was observed in NIH3T3 cells. In a ®rst step toward elaborating the mechanism for cyclin D1-mediated induction of p21 gene expression we show that co-expression of E2F-1 and DP-1 can speci®cally transactivate the p21 promoter. In support of these ®ndings and a direct eect of E2F on induction of p21 gene expression a putative E2F binding site was identi®ed within the p21 promoter. In summary, our results demonstrate that ectopic expression of cyclin D1 can induce gene expression of the cdk inhibitor p21 through an E2F mechanism the consequences of which are not to growth arrest cells but possibly to stabilize cyclin D1/cdk function.
Introduction
Progression through a late-G 1 phase restriction point de®nes the time in the cell division cycle when cells lose their dependency on mitogens and commit to DNA synthesis (Pardee, 1989) . This transition is controlled by G 1 cyclins, including D and E type cyclins and their cyclin-dependent kinases (cdks), whose phosphorylation of the retinoblastoma gene product (pRB) and pRB-related proteins facilitates entry into S phase (Sherr, 1994) . Hypophosphorylated pRB has been shown to bind the transcription factor E2F resulting in an inhibition of E2F-dependent transcription (Bagchi et al., 1991; Chellappan et al., 1991; Chittenden et al., 1991) . This repression is relieved following phosphorylation of pRB by the G 1 cyclindependent kinases (Hinds et al., 1992; Dowdy et al., 1993; Ewen et al., 1993; Kato et al., 1993) .
D type cyclins associate with either cdk4 or cdk6 to form holoenzymes whose activities are ®rst detected in mid-G 1 phase and increase as cells approach the G 1 /S boundary (Baldin et al., 1993) . Overexpression of cyclin D1 and cyclin E in rodent ®broblasts causes a reduction in cell size, reduces the requirement for growth factors and shortens the G 1 interval (Ohtsubo and Roberts, 1993; Quelle et al., 1993; Resnitzky et al., 1994) . These ®ndings indicate that both classes of G 1 cyclins control rate-limiting events for the G 1 /S transition. Because the G 1 cyclins are critical in the decision to pass the restriction point, it is not surprising that deregulated expression of G 1 cyclins and/or their cdk partners is often found in human malignant cells. Many aberrations in G 1 -associated processes are observed in cancer cells, in which cyclin D1 abnormalities are the most prominent (Lammie et al., 1991; Motokura et al., 1991; Schuuring et al., 1992; Jiang et al., 1992) . In addition, overexpression of cyclin D1 contributes to the oncogenic transformation of cells in vitro and in vivo (Jiang et al., 1993; Lovec et al., 1993; Bodrug et al., 1994; Wang et al., 1994) .
Recent studies have identi®ed regulatory subunits for cdks, the cdk inhibitory proteins, including p21 and p27 which bind the cyclin/cdk complex and inhibit its activity. p21 inhibits a wide variety of cyclin/cdk complexes including cyclin D/cdk4-6 and cyclin A ± E/cdk2 complexes (Xiong et al., 1993) . Transcription of p21 is induced both by the tumor suppressor p53 (ElDeiry et al., 1993) and by p53-independent mechanisms (Jiang et al., 1994; Sheikh et al., 1994; Steinman et al., 1994) . Induction of p53 and p21 by irradiation of cells with X-rays blocks the cell cycle at the G 1 /S transition (Dulic et al., 1994) . p21 is also induced during dierentiation (Steinman et al., 1994; Halevy et al., 1995; Macleod et al., 1995; Parker et al., 1995) and following TGF-b stimulation in a p53-independent manner (Datto et al., 1995; Reynisdottir et al., 1995) , indicating that its upregulation is involved in a number of dierent growth-arresting signals. Moreover, p53-independent induction of p21 is also observed following stimulation with serum or puri®ed growth factors (Macleod et al., 1995; Liu et al., 1996) , suggesting that its physiological function is not limited to the execution of cell cycle-arrest programs and p21 must play a more dynamic role in the control of cell growth (Hunter, 1993; Sherr and Roberts, 1995) . In contrast to oncogenic transformation caused by ectopic expression of cyclin D1, ectopic expression of p21 inhibits oncogene-mediated transformation of NIH3T3 cells (Michieli et al., 1996) and causes in human malignant melanoma an accumulation of cells in G 0 / G 1 , altered morphology, and increased melanin production (Yang et al., 1995) .
In this study, we established pools of cyclin D1 transduced human glioma and rodent ®broblast cells in which cyclin D1 expression could be regulated with tetracycline. We found that ectopic expression of cyclin D1 in asynchronously growing cells was accompanied by increased levels of p21 protein in both cell lines and increased p53 tumor suppressor protein in the human glioma cells. Remarkably, despite the induction of these cell cycle inhibitory proteins, cyclin D1-associated cdk kinase remained activated, and cell proliferation was unchanged compared to the parent cells. We also found that in both cell types morphological changes characteristic of transformation were clearly evident in 495% of the cells and that cells not already transformed had acquired the ability to grow in an anchorage-independent manner. The remaining 55% of the cells showed an enlarged and¯attened morphology and were intensely positive for nucleuslocated p21 protein when stained with p21 antibody. Lastly, we examined the mechanism of p21 induction by ectopic expresssion of cyclin D1 and found that the elevated levels of p21 protein were a consequence of activation of the p21 gene. Moreover, we found that this activation was mediated by the transcription factor E2F-1.
Results

Tetracycline-regulated cyclin D1 expression
To study the eect of ectopic expression of cyclin D1 on cell cycle control, we cloned the human cyclin D1 cDNA into a tetracycline regulatable retroviral vector, which allows expression of cyclin D1 in the absence of tetracycline, but not in the presence (Paulus et al., 1996) . Infectious retrovirus were generated and used to infect U343 human glioma cells and NIH3T3 ®broblasts. We determined in parallel experiments using a lacZ gene containing retrovirus (pBABE-lacZ) that the eciencies of infection of U343 and NIH3T3 cells were 100% and 30 ± 40%, respectively. Infected U343 cells were designated U343-D1 and used as a pool without further selection. Infected NIH3T3 were designated 3T3-D1 and placed under puromycin selection (1 mg/ml) in the presence of tetracycline (2 mg/ml) for 10 days before using as a pool.
The levels of endogenous and ectopically expressed cyclin D1 in the parent and infected pools of cells with or without tetracycline were determined using Western blotting analysis (Figure 1 ). Ectopic cyclin D1 was clearly induced in asynchronously growing U343-D1 and 3T3-D1 cells in the absence of tetracycline. The levels of cyclin D1 in the presence of tetracycline in both cell lines, on the other hand, were essentially identical to levels observed in parent U343 and NIH3T3 cells (Figure 1 ). Ectopic expression of cyclin D1 was ®rst detectable in U343-D1 cells at 8 h and 3T3-D1 cells 4 h after removal of tetracycline ( Figure  2a) . Maximum levels of expression were observed between 36 ± 48 h in U343-D1 and between 12 ± 48 h in 3T3-D1 after removal of tetracycline. The induction of the virally transduced cyclin D1 gene in the absence of tetracycline were approximately four-to ®vefold in U343-D1 and two-to threefold in 3T3-D1, compared to endogenous cyclin D1 levels.
Increased level of p21, p53 and cdk4 proteins
Because the cdk inhibitory protein p21 can bind cyclin/cdk complexes and thereby inhibiting their activities (Xiong et al., 1993) , we investigated the levels of p21 protein in asynchronously growing U343-D1 and 3T3-D1 cells in the absence of tetracycline. Remarkably, in both cell lines ectopic expression of cyclin D1 resulted in a signi®cant increase in levels of p21 protein (Figure 2a) . Speci®cally, after removal of tetracycline, levels of p21 protein increased within 24 h in U343-D1 cells and within 8 h in 3T3-D1 cells; the levels of p21 at 24, 36 and 48 h after tetracycline removal were substantially higher than levels observed at time 0 h. Reprobing the blots with antibody to p53 revealed an increase in levels of p53 protein at 12 h in U343-D1 cells (Figure 2a ). This increase in levels of p53 followed the appearance of ectopically expressed cyclin D1 by 8 h and preceded the increase in levels of p21 protein by 24 h. It is of note that the status of the p53 gene in U343 cells has previously been shown to be wild-type (Asai et al., 1994) . We were unable to determine the levels of p53 protein in NIH3T3 and 3T3-D1 cells in the absence of tetracycline because of the relatively low abundance of p53 in this cell type.
Because of the physical association cdk4 displays with cyclin D1 during cell cycle progression and its importance for G 1 progression as well as the increased levels of the cdk inhibitor p21 in U343-D1 and 3T3-D1 cells ectopically expressing cyclin D1, we examined cdk4 protein levels in these cells. Cdk4 protein levels were markedly increased in U343-D1 cells at 36 and 48 h after removal of tetracycline and between 12 and 48 h in 3T3-D1 cells (Figure 2a ).
Cyclin D1-associated cdk kinase activity and cell proliferation in U343-D1 and 3T3-D1 cells
Our results demonstrate that ectopic expression of cyclin D1 in asynchronously growing U343-D1 and Figure 1 Regulated expression of cyclin D1 in infected U343 and NIH3T3 cells. Parental and infected cells were seeded in dishes in either the presence (2 mg/ml) (U343-D1, 3T3-D1) or absence (U343, NIH3T3) of tetracycline. Twenty-four h later cells were washed with PBS and fresh media containing 10% FCS with (U343-D1+, 3T3-D1+) or without (U343, U343-D17, NIH3T3, 3T3-D17) tetracycline was added. After incubation for an additional 24 h, cell lysates were prepared and equal amounts of lysate (50 mg) were analysed by Western blotting and probed with antibody to cyclin D1
3T3-D1 cells increases the relative levels of p53, p21 and cdk4 protein. We next investigated the eect of induction of these cell cycle regulatory proteins on cell cycle progression and cell proliferation. Because activated cyclin D1/cdk kinase is required for the G 1 to S progression, we measured the levels of cyclin D1-associated cdk kinase activity using GST-Rb-Cterm protein as substrate over time in U343-D1 and 3T3-D1 cells where tetracycline had been withdrawn. Cyclin D1/cdk kinase activity increased approximately twofold between 36 and 48 h in U343-D1 cells ( Figure 2b ). The increase in cyclin D1/cdk activity in 3T3-D1 cells was slightly lower than that observed in U343-D1 cells, but did correlate with ectopically expressed cyclin D1 levels ( Figure 2b ). Flow cytometric analysis indicated, however, that ectopic expression of cyclin D1 caused no pronounced cell cycle redistribution (data not shown). The growth or proliferation rates of U343-D1 and 3T3-D1 cells were also investigated ( Figure 3 ). Both cell lines grew exponentially after removal of tetracycline. Their growth rates were, in fact, quite similar to that of parent U343 and NIH3T3 cells. In addition, the growth rates of U343-D1 and 3T3-D1 cells in the continued presence of tetracycline were essentially identical to the growth rates of these cells in the absence of tetracycline and parent U343 and NIH3T3 cells (Figure 3 ). These results are consistent with previous studies demonstrating that cell populations ectopically expressing cyclin D1 have growth rates similar to untransfected cell populations when the cells are cultured in medium containing 10% fetal calf serum ( Morphological changes in U343-D1 and 3T3-D1 cells correlate with positive nuclear staining for p21
Growth rates for U343-D1 and 3T3-D1 in the presence or absence of tetracycline, and parent U343 and NIH3T3 cells were virtually identical. Microscopic examination of U343-D1 and 3T3-D1 cells grown in the absence of tetracycline, however, identi®ed cells in both infected pools that had undergone morphological changes (Figure 4a , f). In the absence of tetracycline, U343-D1 cells tended to grow in clusters and cell size was smaller than parent U343 cells ( Figure 4a ; arrow heads). Interestingly, a minor population (3 ± 5%) of U343-D1 cells demonstrated a¯attened and enlarged morphology compared to parent cells (Figure 4a ; arrows). Similarly, the vast majority of 3T3-D1 cells in the absence of tetracycline were smaller, slightly rounded and grew in clusters ( Figure 4f ; arrow heads) when compared to parent NIH3T3 cells; similar to U343-D1 cells, a small population of these cells (1 ± 2%) also demonstrated a¯attened and enlarged morphology (Figure 4f ; arrows). Morphological changes observed in both cells types were most detectable 3 days after removal of tetracycline. We next immunostained U343-D1 and 3T3-D1 cells grown in the absence of tetracycline with p21 antibody (Figure 4b ± c, g ± h). As was expected based on the results of our Western blotting analysis most U343-D1 cells showed positive immunostaining for p21 in the nucleus (Figure 4b) . Interestingly, the staining was more intense in the¯attened and enlarged cells ( Figure  4c) . Similarly, virtually all of the 3T3-D1 cells exhibited strong immunostaining for p21 (Figure 4g ). Figure 2 (a) Induction of cyclin D1 protein and increased levels of p21, p53 and cdk4 proteins in U343-D1 and 3T3-D1 cells after removal of tetracycline. Cells were seeded in dishes in complete media containing 10% FCS in the presence of tetracycline (2 mg/ml). Twenty-four h later cells were washed and media containing 10% FCS (without tetracycline) was added. Total cell lysates were prepared at the indicated times and equal amounts of lysate (50 mg) were analysed by Western blotting and probed with antibodies to the indicated proteins. (b) Activation of cyclin D1-associated Rb kinase activity in U343-D1 and 3T3-D1 cells after removal of tetracycline. Equal amounts of lysate from the indicated times were immunoprecipitated with anti-human cyclin D1 antibody. The immunoprecipitates were then examined in in vitro kinase reactions using GST-Rb-cterm as substrate
The enlarged and¯attened 3T3-D1 cells showed intense nuclear p21 immunostaining that was very similar to that observed in U343-D1 cells (Figure 4h ). Control immunostaining for p21 of parent U343 and NIH3T3 cells, and U343-D1 and 3T3-D1 grown in the presence of tetracycline showed only weak immunostaining ( Figure 4d , i, e, j).
3T3-D1 cells form colonies in soft agar
The smaller and slightly rounded-up morphology of U343-D1 and 3T3-D1 cells induced by ectopic cyclin D1 expression indicates these cells may be taking on a transformed phenotype, especially in 3T3-D1 cells. To investigate this possibility, we examined U343-D1 and 3T3-D1 cells grown in the absence of tetracycline for anchorage-independent growth (Table 1 and Figure 5 ). Parent NIH3T3 cells failed to form colonies and remained as single cells when suspended in complete growth medium containing 0.3% agar. However, 3T3-D1 cells formed numerous small colonies when grown in the absence of tetracycline. U343-D1 cells were derived from a malignant glial tumor and not surprisingly formed about the same number of colonies as did parent U343 cells (Table 1) . These results con®rm previous studies demonstrating that ectopic expression of cyclin D1 in rodent ®broblasts is sucient to induce a transformed phenotype (Jiang et al., 1993; Asano et al., 1995) .
Ectopic expression of cyclin D1 can activate transcription of the p21 gene through p53-independent pathway
Our Western blotting data demonstrate that p21 levels are markedly increased by ectopic expression of cyclin D1 ( Figure 2a ). However, it is unclear whether the increased levels of p21 protein are due to increased protein stability or transcriptional activation of the p21 gene. We examined the possibility that cyclin D1 can eect transcription of the p21 gene by using p21 promoter-luciferase reporter constructs (El-Deiry et al., 1993) . The WWP-p21-Luc reporter construct contains a p53 binding site and DM-p21-Luc is deleted for the p53 binding site. U343, U343-D1, NIH3T3 and 3T3-D1 cells were transiently cotransfected with an internal control RSV-CAT reporter construct and either the WWP-p21-Luc or DM-p21-Luc reporter constructs. Ectopic expression of cyclin D1 was turned on after cotransfection of U343-D1 and 3T3-D1 cells by removal of tetracycline. Both p21 promoter constructs, WWP-p21-Luc and DM-p21-Luc, showed substantially higher levels of luciferase expression in U343-D1 and 3T3-D1 cells ( Figure 6 ). The induction of luciferase activity was three-to fourfold in U343-D1 and eight-to ninefold in 3T3-D1, compared to parent U343 and NIH3T3 cells, respectively. These data suggest that ectopic expression of cyclin D1 can induce transcriptional activation of the p21 gene through a p53-independent pathway.
E2F-1 activation of the p21 gene
Our data show that ectopic expression of cyclin D1 can activate transcription of the p21 gene. Because it has been shown previously that several dierent types of cyclins (including D type) can activate the E2F promoter (Schulze et al., 1994; Shao and Robbins, 1995; Johnson, 1995) , we investigated whether cyclin D1 activates p21 expression through an E2F mechanism. U343 cells were transfected with WWP-p21-Luc or B-myb-Luc promoter reporter constructs and expression vectors encoding E2F-1 (pCMV-E2F1) and DP-1 (pCMV-DP1). The B-myb promoter has been shown previously to be transactivated by E2F-1 in transient transfections of human HeCaT and mouse NIH3T3 cells (Lam et al., 1995; Bennet et al., 1996) . DP is the heterodimeric partner of E2F and dimerization A B Figure 3 Cell viability of U343-D1 and 3T3-D1 cells. U343-D1 cells (a) and 3T3-D1 cells (b) were grown in complete media containing 10% FCS with tetracycline (U343-D1+ and 3T3-D1+) or without tetracycline (U343-D17, 3T3-D17) for the indicated times and then cell viability and cell number were determined using the trypan blue inclusion method. Parental U343 cells (a) and NIH3T3 cells (b) were included as controls. All time points were done in triplicate and standard deviations are indicated between E2F-1 and a DP-1 is essential for high-anity DNA binding, transcriptional activation, and binding to pocket proteins (Helin et al., 1993; Wu et al., 1995) . As expected there was an increase in luciferase activity when U343 cells were transfected with the positive control B-myb-Luc reporter (8.4-fold over that observed in the absence of pCMV-E2F1 and pCMV-DP1) (Figure 7a ). Remarkably, in cells transfected with WWP-p21-Luc, we also observed a signi®cant increase in luciferase activity (3.2-fold over that observed in the absence of pCMV-E2F1 and pCMV-DP1) (Figure 7a ). The latter results indicate that E2F1 can transactivate a p21 promoter reporter that includes 2400 bp of DNA upstream to the start site of transcription. To de®ne Similar to that observed with WWP-p21-Luc a relatively strong induction of luciferase activity was observed (4.9-fold over that observed in the absence of pCMV-E2F1 and pCMV-DP1) (Figure 7a ). These results demonstrate that the 7215 region of the p21 promoter is sucient for E2F transactivation and raises the possibility that E2F binding sites occur within this region of the p21 gene. Indeed, between 7155 to 7148 within the human p21 promoter is the sequence CTCCGCGC that shares a high degree of similarity with the E2F recognition sequence TTTCGCGC found in the E2 promoter (Nevins, 1992) (Figure 7b ).
Discussion
A remarkable ®nding of this study is that protein levels of the cdk inhibitor p21 are induced in human glioma and mouse ®broblast cell lines ectopically expressing cyclin D1. When the growth rates of U343-D1 and 3T3-D1 were measured and compared with that of the parent cells, growth rates were found to be virtually identical. Transfection experiments using a p21 promoter reporter construct lacking the p53 binding site demonstrated that transcriptional activation of the p21 gene can occur through a p53-independent pathway in both U343-D1 and 3T3-D1 cells in the absence of tetracycline. However, our Western blotting data showed that ectopic expression of cyclin D1 in U343-D1 cells correlated with increased levels of p53 protein. Thus, it is possible that p53 can also contribute to activation of the p21 gene. As a ®rst step toward elucidating the mechanism for cyclin D1 activation of the p21 gene, we have determined that the p21 gene can be transactivated by E2F and that this transactivation is likely due to the presence of a potential E2F recognition site within the p21 promoter.
The connection between E2F-1 and cyclin D1 is that E2F-1 is activated by derepression of the E2F-1 promoter by cyclin D/cdk complexes (Johnson, 1995) . Taken together, these results strongly suggest that the induction of p21 in U343-D1 and possibly 3T3-D1 cells observed with ectopic expression of cyclini D1 is likely to be mediated by E2F-1 (Figure 8 ). 
No. of colonies a 0 225 137 142 a A total of 3000 cells of each cell line were seeded into 0.3% agar, and the number of colonies were counted after 2 weeks.
b The cells were seeded and incubated in the absence of tetracycline Figure 6 Transcriptional activation of the p21 gene in U343-D1 and 3T3-D1 cells after removal of tetracycline. Cells were transiently cotransfected with 5 mg of either WWP-p21-Luc (WWP) or DM-p21-Luc (DM) and 3 mg of RSV-CAT plasmid DNA. After transfection, ectopic expression of cyclin D1 was turned on by the removal of tetracycline. Thirty six h later, cells were harvested and lysates were assayed for luciferase and CAT activities. The results are representative of three separate experiments. Luciferase activity is expressed as arbitrary light units normalized to CAT activity and total protein concentration Previous studies have established that p21 can function as a universal inhibitor of cyclin/cdk catalytic activity (Xiong et al., 1993; Harper et al., 1995) . However, p21 does not always function as a cyclin/cdk inhibitor based on the ®ndings that in proliferating cells the majority of p21 protein is found in active cyclin/cdk complexes (Zhang et al., 1994) . A proposed explanation for this paradox is that cyclin/cdk complexes containing a single p21 molecule are still catalytically active in terms of cell cycle progression, whereas complexes containing multiple p21 subunits are inactive (Zhang et al., 1994; Harper et al., 1995) . Thus, the absolute ratio between p21 and the cyclin/ cdk complexes determines the cell cycle inhibitory behavior of p21. In U343-D1 and 3T3-D1 cells, the increased levels of p21 protein that are induced by increased levels of cyclin D1 likely coordinate to form a stable and active cyclin D1/cdk/p21 complex that allows the cells to continue to negotiate S phase and results in a transformed phenotype. Although p21 and cyclin D1 levels are increasing in this situation the stoichiometry between the cyclin D1/cdk complex and p21 likely does not change and a stable and active cyclin D1/cdk/p21 complex is sustained. If, however, the increased level of p21 protein overcomes that of cyclin D1/cdk, the ratio of the cyclin D1/cdk complexes to p21 is biased toward p21 (more than one p21 molecule) and cyclin D1/cdk activity is inhibited due to the binding of multiple p21 subunits. The outcome in this situation would be suppression of cell cycle progression possibly accompanied by cellular dierentiation (Figure 8 ). This explanation is still hypothetical and further experiments will be needed to determine whether cyclin D1/cdk to p21 ratios are indeed important for cell cycle progression and transformation or cell cycle suppression and differentiation.
Microscopic examination of U343-D1 and 3T3-D1 cells that ectopically express cyclin D1 identi®ed two dierent groups of cells in both cell lines. The majority of U343-D1 and 3T3-D1 cells displayed a reduction in cell size and in the case of 3T3-D1 acquired the ability to grow in an anchorageindependent manner. The phenotype of U343-D1 and 3T3-D1 cells grown in the absence of tetracycline is consistent with previous data demonstrating that overexpression of cyclin D1 contributes to the oncogenic transformation of cells in vitro and in vivo (Jiang et al., 1993; Wang 1994; Asano et al., 1995) . The second and far less frequent group of cells observed in both cell lines when grown in the absence of tetracycline exhibited a¯attened and enlarged morphology indicative of a more dierentiated state. The¯attened and enlarged variants were never observed in the parental U343 and NIH3T3 cells or when U343-D1 or 3T3-D1 cells were grown in the presence of tetracycline. Similar morphological changes have been observed in several dierent cell types with the introduction of p21, wild-type p53, pRB or p16 (Sheikh et al., 1995; Huang et al., 1988; In response to a cell cycle progression stimulus or ectopic cyclin D1 expression, E2F is released and accumulates following the phosphorylation of pRB by cyclin D1/cdk4. Liberated E2F then is able to bind the p21 promoter and activate transcription of the p21 gene. Even though cyclin D1 and p21 protein levels are increasing, as long as the stoichiometry between the cyclin D1/cdk complexes and p21 are kept constant (where cyclin D14p21) the cell continues to divide. In this situation the cell would also likely no longer be able to respond to p21-mediated growth inhibitory signals due to the existing high levels of p21. The outcome of this state would be cellular transformation. Conversely, when p21 levels are greater than cyclin D1 levels the cell cycle machinery is suppressed and/or shifted toward a direction of dierentiation Van Meir et al., 1995; Fueyo et al., 1996; GomezManzano et al., 1996) . It has recently been shown that several factors that promote cell dierentiation induce expression of p21, even in cells lacking functional p53 (Jiang et al., 1994; Steinman et al., 1994; Datto et al., 1995; Macleod et al., 1995) . Expression of p21 in various tissues during mouse development, moreover, correlates with the appearance of post-mitotic, dierentiating cells (Halevy et al., 1995; Parker et al., 1995) . The intense nuclear staining of p21 observed in the enlarged and¯attened U343-D1 and 3T3-D1 cells when cyclin D1 expression was turned on is consistent with high level expression of p21 being associated with dierentiation.
A positive feedback by a cdk inhibitor that potentially functions to stabilize cell cycle progression has been observed in the HC11 mouse mammary epithelial cell line that overexpresses cyclin E (Sgambato et al., 1996) . In these cells, overexpression of cyclin E induces high levels of the cdk inhibitor, p27 which parallels cell cycle progression. Similarly, in our experiments we observed induction of p21 gene expression by ectopic expression of cyclin D1 in U343-D1 and 3T3-D1 cells. In this regard, induction of p21 gene expression has been observed following mitogenic stimulation and is found to parallel upregulation of cdk activity (Macleod et al., 1995; Liu et al., 1996) . These results provide a correlation with our results and taken together suggest that the various cdk inhibitors, for instance p21 and p27, may play a regulatory role in growing cells by setting a threshold level that cyclin/cdk complexes must overcome before progression to the next phase of the cell cycle can occur.
Our results demonstrating that E2F can transactivate the p21 gene are of particular note since mutations that inactivate pRB or pathways that regulate pRB phosphorylation have been found in a large number of tumor cells. Mutations that eect the phosphorylation state of pRB include inactivation of p16, ampli®cation of cyclin D1 and mutation or ampli®cation of cdk4 (Horowitz et al., 1990; Lammie et al., 1991; Jiang et al., 1992; He et al., 1994; Kamb, 1995; Weinberg et al., 1995; Wolfel et al., 1995) . These observations suggest that deregulation of E2F-dependent transcription may be a common feature of human tumor cells (Du et al., 1996) . Taken together with the observation that the p21 gene contains an E2F binding site in its promoter region it is possible that deregulated expression of E2F stimulates p21 gene expression. This would provide a plausible explanation for the high levels of p21 protein observed in several dierent human tumors. An example of this is observed in gliomas where the majority of the glial tumors express elevated levels of p21 protein regardless of their malignancy grades (Jung et al., 1995) . Another example is seen in non-small cell lung carcinomas where p21 RNA and protein levels are higher in the tumors than in the corresponding normal tissues (Marchetti et al., 1996) . Elevated p21 levels may play a regulatory role in stabilization of cell cycle progression, even in tumor cells, by setting a threshold level in the G 1 phase that deregulated regulatory subunits (i.e. cdks, cyclins) must overcome before progression to the next phase of the cell cycle can occur. This study highlights a potential novel aspect of p21 activity in the cell cycle machinery.
Materials and methods
Construction of cyclin D1 retroviral vector
The complete coding region of cyclin D1 was excised from pBSKS-D1 (kindly provided by Michele Pagano) with NotI and cloned into the NotI site of pBPSTR-1. The resulting construct was designated pBPSTR-D1. pBPSTR-1 is a retroviral vector constructed and described previously (Paulus et al., 1996) that contains both elements of the tetracycline-regulated system (Gossen and Bujard, 1992) . The puromycin resistance gene, under the control of the promoter within the 5'-LTR, is also present in pBPSTR-1.
Cell culture
The following cell lines were used: U343 human glioma cells (kindly provided by Mark Israel), mouse NIH3T3 ®broblasts (American Type Culture Collection), the ecotropic packaging cell line BOSC23 (Pear et al., 1993) , and the amphotrophic packaging cell c-CRIP (American Type Culture Collection). All cells lines were grown in Dulbecco's modi®ed Eagle's medium (Mediatech) supplemented with 10% fetal calf serum (FCS) and penicillin Gstreptomycin sulfate.
Transfections and infections
Ecotropic retrovirus were generated by transfecting BOSC23 cells with 15 mg of pBPSTR-D1 or pBABElacZ plasmid DNA essentially as described previously (Pear et al., 1993) . After transfection, cells were grown in the presence of tetracycline (1 mg/ml) (Sigma) during packaging of virus to increase titers. NIH3T3 cells were then infected with the retrovirus-containing supernatants containing 4 mg/ml Polybrene (Sigma) and 2 mg/ml tetracycline for 16 h. Amphotropic retrovirus were generated by infecting c-CRIP cells with the retrovirussupernatants from BOSC23 cells (transfected 48 h earlier) containing 8 mg/ml Polybrene and 2 mg/ml tetracycline. Retrovirus-supernatants from c-CRIP cells were harvested 48 h post-infection and used for infection of U343 cells containing 8 mg/ml Polybrene and 2 mg/ml tetracycline.
Protein extraction and Western blotting 1.5610 6 of U343, U343-D1 cells and 1.0610 6 of NIH3T3, 3T3-D1 cells were seeded in 150 mm dishes with 2 mg/ml of tetracycline (U343-D1, 3T3-D1) or without tetracycline (U343, NIH3T3). Twenty-four h later cells were washed extensively with PBS and refed with DMEM containing 10% FCS with (U343-D1+, 3T3-D1+) or without (U343-D17, 3T3-D17, U343, NIH3T3) tetracycline. Total cell extracts were then prepared at the indicated times after washing by homogenizing the cells in lysis buer (1% SDS, 10 mM Tris-HCl, pH 7.4). The extracts were boiled for 5 min and centrifuged at 15 000 r.p.m. for 10 min after DNA shearing by multiple syringe passages. Protein concentrations were determined using the DC Protein Assay (Bio-Rad, Hermes, CA). Equal amounts of lysate (50 mg) were boiled for 4 min in SDS-sample buer and subjected to 12.5% SDS ± PAGE and then transferred to nitrocellulose membranes (Bio-Rad). Filters were probed as described previously (Jiang et al., 1993) with cyclin D1 (Upstate Biotechnology, Inc.), cdk4 (Santa Cruz Biotechnology), p53 (Calbiochem) and p21 (Santa Cruz Biotechnology) antibodies. After washing in HBS-tween buer, the ®lters were incubated with horseradish peroxidase-conjugated goat anti-rabbit or horse anti-mouse IgG antibody (Vector Laboratories Inc., Burlingame, CA). Proteins were detected with ECL detection reagents (Amersham).
In vitro kinase assays U343-D1 and 3T3-D1 cells were grown in the absence of tetracycline for the indicated time and lysed as previously described (Matsushime et al., 1994) . Equal amounts of cell lysate were immunoprecipitated with anti-human cyclin D1 antibody (DCS-11) (kindly provided by Jiri Bartek). The immunoprecipitates were then incubated for 30 min at 378C in 30 ml of kinase buer (50 mM HEPES at pH 7.5, 10 mM MgCl 2 , 1 mM DTT) containing 2.5 mM EGTA, 10 mM b-glycerophosphate, 0.1 mM sodium orthovanadate, 1 mM NaF, 20 mM ATP, 10 mCi of [g-32 P]ATP, and 1 mg of GST-Rb-Cterm (Meyerson and Harlow, 1994) . Samples were boiled in polyacrylamide gel sample buer containing SDS and separated by electrophoresis. Phosphorylated proteins were visualized by autoradiography of the dried slab gels.
Cell growth rate analysis
Cells were seeded in 6-well plates in triplicate at a density of 2.5610 4 cells per well in DMEM with or without tetracycline. Twenty-four h later that day (day 0), the cells were washed with PBS and refed with DMEM containing 10% FCS with or without tetracycline. Total cell numbers were counted on day 0, 1, 2, 3, 4 and 5 by the trypan blue exclusion method.
Immunocytochemistry assay
Cells were ®xed in ice cold methanol-acetone (1 : 1) and treated with 0.1% hydrogen peroxidase for 5 min to block endogenous peroxidase activity. Immunostaining was performed using the Vectastain Elite Kit (Vector Laboratories Inc, Burlingame, CA). The primary polyclonal antip21 antibody (C-19) was obtained from Santa Cruz Biotechnology Inc, and the secondary antibody was a biotinylated anti-rabbit IgG (Vector Laboratories Inc, Burlingame, CA). Diaminobenzidine was used as a substrate for the biotinylated horseradish peroxidase avidin-biotin complex.
Soft agar cloning assay
Three thousand cells were seeded into 6-well plates in DMEM containing 10% FCS and 0.3% low-melting-point agarose over a base of 0.5% agarose in a humidi®ed atmosphere containing 5% CO 2 at 378C. Two weeks after seeding, colonies were counted and photographed.
Luciferase assay
5610
5 of U343, U343-D1 and 3610 5 of NIH3T3, 3T3-D1 cells were seeded into 100 mm dishes with media containing tetracycline (U343-D1, 3T3-D1) or media alone (U343, NIH3T3). Twenty-four h later, cells were cotransfected with either WWP-p21-Luc or DM-p21-Luc (kindly provided by B Vogelstein) and RSV-CAT (kindly provided by A Symes) plasmid DNA using the calcium phosphate method. After 12 h, cells were washed twice with PBS and then incubated for 36 h in DMEM containing 10% FCS. Cell lysates were collected and assayed for luciferase and chloramphenicol acetyltransferase (CAT) activities as described previously (Paulus et al., 1996) .
For E2F transactivation of the p21 promoter studies, U343 cells were cotransfected with WWP-p21-Luc or (7215)-p21-Luc or B-myb-Luc and pCMV-E21F1, pCMV-DP1, RSV-CAT. B-myb-Luc, pCMV-E2F1 and pCMV-DP1 were kindly provided by M Classon. (7215)-p21-Luc, which contains 215 bp upstream from the start site of transcription in the human p21 gene, was kindly provided by LP Freedman.
